Although both parents and pediatricians understand the need to treat kids with hypertension, few believe the diagnosis or ...
The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...
Gestational hypertension, preeclampsia, and eclampsia are associated with an increased risk for neurological outcomes in the months or years after giving birth.
The Paradise uRDN system is currently commercially available for patients in the US having received FDA approval in November ...
Medtronic plc , a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal ...
Hypertension (HTN) increases the risk of development of HF and it precedes it in 75% of cases. HF patients are nearly evenly divided between those with reduced left ventricular (LV) function or ...
Medtronic and Recor Medical, Inc. separately announced that the Centers for Medicare & Medicaid Services (CMS) is opening a ...
A new study published in the journal of BMC Endocrine Disorders showed that a high-quality carbohydrate diet with increased ...
Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...